Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsForexCryptocurrenciesCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Sander J. van Deventer
Age : 64
Public asset : 3,090,481 USD
Linked companies : uniQure N.V. - HOOKIPA Pharma Inc.
Founder of uniQure NV, Amsterdam Molecular Therapeutics (AMT) Holding NV and Dezima Pharma BV, Sander J. van Deventer is an entrepreneur who presently occupies the position of Executive VP-Research & Product Development at uniQure NV.

He is also Professor at Leids Universitair Medisch Centrum and on the board of 5 other companies.

In his past career he was Managing Partner at Forbion Capital Partners Management Holding BV, Professor at Academic Medical Center, Director at Amsterdam Molecular Therapeutics (AMT) Holding NV, Chief Executive Officer for Dezima Pharma BV and Professor-Experimental Medicine at the University of Amsterdam.

He received an undergraduate degree and a doctorate from the University of Amsterdam.

Current positions of Sander J. van Deventer 
NameTitle Since
uniQure N.V.
(Biotechnology & Medical Research)
Executive VP-Research & Product Development 2019
HOOKIPA Pharma Inc.
Independent Director 2011
enGene, Inc. Director -
gIcare Pharma, Inc. Director -
Hookipa Biotech AG Member-Supervisory Board 2013
Staten Biotechnology BV Director -
Leids Universitair Medisch Centrum Professor 2008

Holdings of Sander J. van Deventer 
uniQure N.V. (QURE)
(Biotechnology & Medical Research)
43,1270.10%3,090,481 USD

Sander J. van Deventer: Personal Network 
Most Read News 
02/14WARREN BUFFETT : Buffett's Berkshire buys Kroger and Biogen, reduces Wells Fargo and Goldman stakes
02/12ALFRED SCHINDLER : Thyssenkrupp-Kone elevator merger would trigger legal war - Schindler
02/17ELON MUSK : Elon Musk Has Changed Investors' Views on the Electric Car
02/13TIDJANE THIAM : Investment bank loss mars Thiam's final act at Credit Suisse
02/17JEFF BEZOS : Amazon's Bezos pledges $10 billion to climate change fight
02/14ALFRED SCHINDLER : Schindler sees coronavirus hit of 'several hundreds of millions'
02/15MARK ZUCKERBERG : Treat us like something between a telco and a newspaper, says Facebook's Zuckerberg
02/15MARK ZUCKERBERG : Zuckerberg
02/16THOMAS RABE : Rabe
02/12JEFF BEZOS : Bezos buys Warner Estate in Beverly Hills for record $165 million
More news

© 2020 People and Ownership :   
Sander J. van Deventer : Connections 
Sentry Hill Partners LLC
Corvidia Therapeutics, Inc.
Direct Relief International
Celdara Medical LLC
Elusys Therapeutics, Inc.
HotSpot Therapeutics, Inc.
Vaccines Holdings Sweden AB
Forbion Capital Partners Management Holding BV
University of Utrecht
Regenesance BV
EryDel SpA
Creabilis Therapeutics SRL

Popular Business Leaders 
Bernard Arnault Mark Bertolini Jeff Bezos Michael Bloomberg Thierry Bolloré Thierry Breton Warren Buffett David Calhoun Jean-louis Chaussade Jean-pierre Clamadieu Tim Cook Jean-charles Decaux Clotilde Delbos Michael Dell Herbert Diess Jamie Dimon James Gorman Paul Hudson Carl Icahn Travis Kalanick Isabelle Kocher Arnaud Lagardère Jack Ma Yusaku Maezawa Martina Merz Lakshmi Mittal Dennis Muilenburg Elon Musk Jean-charles Naouri Xavier Niel Alexander Novak Larry Page Mark Parker Sundar Pichai Patrick Pouyanné Alexandre Ricard Urs Rohner Remo Ruffini Bernd Scheifele Alfred Schindler Jean-dominique Senard David Simon Masayoshi Son Friede Springer Carlos Tavares Tidjane Thiam Theodor Weimer Mark Zuckerberg Luca De Meo Isabel Dos Santos
A-Z Business Leaders